Protective Role of Stem Cells in POI: Current Status and Mechanism of Action, a Review Article

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Jan 3

PMID 38169739

Authors

Somaye Sadeghi

Nariman Mosaffa

Boxian Huang

Fahimeh Ramezani Tehrani

Affiliations

Soon will be listed here.

Abstract

Premature ovarian insufficiency (POI) has far-reaching consequences on women's life quality. Due to the lack of full recognition of the etiology and complexity of this disease, there is no appropriate treatment for infected patients. Recently, stem cell therapy has attracted the attention of regenerative medicine scholars and offered promising outcomes for POI patients. Several kinds of stem cells, such as embryonic stem cells (ESCs), mesenchymal stem cells (MSCs), and induced pluripotent stem cells (iPSCs) have been used for the treatment of ovarian diseases. However, their potential protective mechanisms are still unknown. Undoubtedly, a better understanding of the therapeutic molecular and cellular mechanisms of stem cells will address uncover strategies to increase their clinical application for multiple disorders such as POI. This paper describes a detailed account of the potential properties of different types of stem cells and provides a comprehensive review of their protective mechanisms, particularly MSC, in POI disorder. In addition, ongoing challenges and several strategies to improve the efficacy of MSC in clinical use are addressed. Therefore, this review will provide proof-of-concept for further clinical application of stem cells in POI.

Citing Articles

Exosomes derived from hypoxic mesenchymal stem cell ameliorate premature ovarian insufficiency by reducing mitochondrial oxidative stress.

Zhang S, Zou X, Feng X, Shi S, Zheng Y, Li Q Sci Rep. 2025; 15(1):8235.

PMID: 40065033 PMC: 11894067. DOI: 10.1038/s41598-025-90879-3.

Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: attractive therapeutic approaches for female reproductive dysfunction.

Hassanpour Khodaei S, Sabetkam S, Kalarestaghi H, Dizaji Asl K, Mazloumi Z, Bahramloo M Mol Biol Rep. 2024; 52(1):10.

PMID: 39576370 DOI: 10.1007/s11033-024-10106-6.

Human mesenchymal stem cells derived exosomes improve ovarian function in chemotherapy-induced premature ovarian insufficiency mice by inhibiting ferroptosis through Nrf2/GPX4 pathway.

Zhou Y, Huang J, Zeng L, Yang Q, Bai F, Mai Q J Ovarian Res. 2024; 17(1):80.

PMID: 38622725 PMC: 11017636. DOI: 10.1186/s13048-024-01403-6.

References

Lange-Consiglio A, Capra E, Herrera V, Lang-Olip I, Ponsaerts P, Cremonesi F . Application of Perinatal Derivatives in Ovarian Diseases. Front Bioeng Biotechnol. 2022; 10:811875. PMC: 8818994. DOI: 10.3389/fbioe.2022.811875. View

Jiao W, Mi X, Yang Y, Liu R, Liu Q, Yan T . Mesenchymal stem cells combined with autocrosslinked hyaluronic acid improve mouse ovarian function by activating the PI3K-AKT pathway in a paracrine manner. Stem Cell Res Ther. 2022; 13(1):49. PMC: 8812195. DOI: 10.1186/s13287-022-02724-3. View

Kuang H, Han D, Xie J, Yan Y, Li J, Ge P . Profiling of differentially expressed microRNAs in premature ovarian failure in an animal model. Gynecol Endocrinol. 2013; 30(1):57-61. DOI: 10.3109/09513590.2013.850659. View

Huang B, Lu J, Ding C, Zou Q, Wang W, Li H . Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD. Stem Cell Res Ther. 2018; 9(1):216. PMC: 6085638. DOI: 10.1186/s13287-018-0953-7. View

Zhao Q, Gregory C, Lee R, Reger R, Qin L, Hai B . MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs. Proc Natl Acad Sci U S A. 2014; 112(2):530-5. PMC: 4299223. DOI: 10.1073/pnas.1423008112. View

Chen X, Wang Q, Li X, Wang Q, Xie J, Fu X . Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovarian granulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure. Stem Cell Res Ther. 2018; 9(1):240. PMC: 6158904. DOI: 10.1186/s13287-018-0964-4. View

Fenton A . Premature ovarian insufficiency: Pathogenesis and management. J Midlife Health. 2016; 6(4):147-53. PMC: 4743275. DOI: 10.4103/0976-7800.172292. View

Liu R, Zhang X, Fan Z, Wang Y, Yao G, Wan X . Human amniotic mesenchymal stem cells improve the follicular microenvironment to recover ovarian function in premature ovarian failure mice. Stem Cell Res Ther. 2019; 10(1):299. PMC: 6775662. DOI: 10.1186/s13287-019-1315-9. View

Huang Q, Chen S, Chen J, Shi Q, Lin S . Therapeutic options for premature ovarian insufficiency: an updated review. Reprod Biol Endocrinol. 2022; 20(1):28. PMC: 8815154. DOI: 10.1186/s12958-022-00892-8. View

10.

Guo C, Sun L, Chen X, Zhang D . Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res. 2014; 8(21):2003-14. PMC: 4145906. DOI: 10.3969/j.issn.1673-5374.2013.21.009. View

11.

Amorin B, Alegretti A, Valim V, Pezzi A, Laureano A, Silva M . Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. Hum Cell. 2014; 27(4):137-50. PMC: 4186969. DOI: 10.1007/s13577-014-0095-x. View

12.

Noory P, Navid S, Zanganeh B, Talebi A, Borhani-Haghighi M, Gholami K . Human Menstrual Blood Stem Cell-Derived Granulosa Cells Participate in Ovarian Follicle Formation in a Rat Model of Premature Ovarian Failure . Cell Reprogram. 2019; 21(5):249-259. DOI: 10.1089/cell.2019.0020. View

13.

Xu H, Chen L, Zhou S, Li Y, Xiang C . Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases. World J Stem Cells. 2020; 12(11):1276-1294. PMC: 7705472. DOI: 10.4252/wjsc.v12.i11.1276. View

14.

Zhao Y, Ma J, Yi P, Wu J, Zhao F, Tu W . Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice. Stem Cell Res Ther. 2020; 11(1):466. PMC: 7641864. DOI: 10.1186/s13287-020-01972-5. View

15.

Cho J, Kim T, Seok J, Jun J, Park H, Kweon M . Vascular remodeling by placenta-derived mesenchymal stem cells restores ovarian function in ovariectomized rat model via the VEGF pathway. Lab Invest. 2020; 101(3):304-317. PMC: 7892345. DOI: 10.1038/s41374-020-00513-1. View

16.

Phetfong J, Sanvoranart T, Nartprayut K, Nimsanor N, Seenprachawong K, Prachayasittikul V . Osteoporosis: the current status of mesenchymal stem cell-based therapy. Cell Mol Biol Lett. 2017; 21:12. PMC: 5414670. DOI: 10.1186/s11658-016-0013-1. View

17.

Berebichez-Fridman R, Montero-Olvera P . Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review. Sultan Qaboos Univ Med J. 2019; 18(3):e264-e277. PMC: 6307657. DOI: 10.18295/squmj.2018.18.03.002. View

18.

Liu C, Yin H, Jiang H, Du X, Wang C, Liu Y . Extracellular Vesicles Derived from Mesenchymal Stem Cells Recover Fertility of Premature Ovarian Insufficiency Mice and the Effects on their Offspring. Cell Transplant. 2020; 29:963689720923575. PMC: 7586265. DOI: 10.1177/0963689720923575. View

19.

Jakob M, Hambrecht M, Spiegel J, Kitz J, Canis M, Dressel R . Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Show Comparable Functionality to Their Autologous Origin. Cells. 2020; 10(1). PMC: 7823915. DOI: 10.3390/cells10010033. View

20.

Ding L, Yan G, Xu L, Gu Y, Ru T, Cui X . Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility. Sci China Life Sci. 2018; 61(12):1554-1565. DOI: 10.1007/s11427-017-9272-2. View